News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
An experimental antibody drug developed by Regeneron Pharmaceuticals called pozelimab could become the first approved treatment of the hereditary immune disease CHAPLE, with a US Food and Drug Administration (FDA) approval decision expected by August 2023.
Nearly $8m AUD ($5.5m USD) in philanthropic funding has been secured to help develop an mRNA vaccine against Group A Streptococcus (Strep A).
mRNA therapeutics have received increased amounts of attention and funding ever since mRNA vaccines proved effective in curbing the spread of the COVID-19 pandemic. Now, researchers are exploring mRNA therapeutics’ use in other disease spaces, reports...
Daiichi Sankyo is kitting out a plant, based near Tokyo in Kitamoto, with equipment to enable the production of an mRNA vaccine against COVID-19, according to a Nikkei Asia report.
J&J, Vir Biotechnology and Ocugen are among the companies welcoming new faces to top jobs.